We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Researchers Lay Groundwork for Graphene-based Diagnostic Devices

By LabMedica International staff writers
Posted on 18 Mar 2019
Print article
Image: Researchers combined graphene with nano-sized metal ribbons of gold to create an ultrasensitive biosensor that could help detect a variety of diseases in humans and animals (Photo courtesy of Oh Group, University of Minnesota).
Image: Researchers combined graphene with nano-sized metal ribbons of gold to create an ultrasensitive biosensor that could help detect a variety of diseases in humans and animals (Photo courtesy of Oh Group, University of Minnesota).
A breakthrough in the use of graphene as a plasmon resonator for ultrasensitive infrared spectroscopy should enable development of new biosensors for detection of diseases at the molecular level.

Graphene is a form of carbon consisting of a single layer of carbon atoms arranged in a hexagonal lattice. It is a semimetal with small overlap between the valence and the conduction bands. As such, it can be considered as an indefinitely large aromatic molecule, the ultimate case of the family of flat polycyclic aromatic hydrocarbons. Graphene is the basic structural element of many other forms of carbon, such as graphite, charcoal, carbon nanotubes and fullerenes. Graphene has many uncommon properties such as being the strongest material ever tested while conducting heat and electricity efficiently and being nearly transparent.

Graphene's remarkable single atom thickness minimizes its efficiency to interact with light that is shined through it. Since light absorption and conversion to local electric fields is essential for detecting small amounts of molecules, this has prevented significant use of graphene as a basis for diagnostic devices.

Investigators at the University of Minnesota (Minneapolis/St. Paul, USA) have now combined graphene with nano-sized metal ribbons of gold. Using sticky tape and a high-tech nanofabrication technique called “template stripping,” they created an ultra-flat base layer surface for graphene that made the material suitable for use as an acoustic plasmon resonator.

Plasmon resonance is a phenomenon that occurs when light is reflected off thin metal films, which may be used to measure interaction of biomolecules on the surface. An electron charge density wave arises at the surface of the film when light is reflected at the film under specific conditions. A fraction of the light energy incident at a defined angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing the reflected light intensity. The angle of incidence at which this occurs is influenced by the refractive index close to the backside of the metal film, to which target molecules are immobilized. If ligands in a mobile phase running along a flow cell bind to the surface molecules, the local refractive index changes in proportion to the mass being immobilized. This can be monitored in real time by detecting changes in the intensity of the reflected light.

The investigators reported that graphene-based acoustic plasmons allowed ultrasensitive measurements of absorption bands and surface phonon modes in ångström-thick protein and SiO2 layers, respectively. The acoustic plasmon resonator platform was scalable and could harness the ultimate level of light–matter interactions at nearly 94% efficiency for potential applications including spectroscopy, sensing, metasurfaces, and optoelectronics. When protein molecules were inserted between the graphene and metal ribbons, enough energy was harnessed to view single layers of protein molecules.

“In order to detect and treat many diseases we need to detect protein molecules at very small amounts and understand their structure,” said senior author Dr. Sang-Hyun Oh, professor of electrical and computer engineering at the University of Minnesota. “Currently, there are many technical challenges with that process. We hope that our device using graphene and a unique manufacturing process will provide the fundamental research that can help overcome those challenges. Our computer simulations showed that this novel approach would work, but we were still a little surprised when we achieved the 94% percent light absorption in real devices. Realizing an ideal from a computer simulation has so many challenges. Everything has to be so high quality and atomically flat. The fact that we could obtain such good agreement between theory and experiment was quite surprising and exciting.”

This work was detailed in the February 11, 2019, online edition of the journal Nature Nanotechnology.

Related Links:
University of Minnesota

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.